A retrospective study indicated that PCSK9 inhibitors in AIS patients undergoing post-mechanical thrombectomy may lead to improved discharge outcomes and decrease the occurrence of hemorrhage and early neurologic deterioration (32). Here, PCSK9 is linked to androgen insensitivity syndrome.